Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor
Clinical trial NCT02544451 · COMPLETED
Trial details
- NCT number
- NCT02544451
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2018-08-01
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.